Zobrazeno 1 - 10
of 3 477
pro vyhledávání: '"C. Giardina"'
Autor:
Michelle A. Gaylord, Melissa Larrier, Donna Giordano-Schmidt, Christopher D. Grube, Suddham Singh, Ha H. Nguyen, Andrew McKeen, Charles Y. Tan, Annaliesa S. Anderson, Warren V. Kalina, Danka Pavliakova, Peter C. Giardina
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTSix serotypes (Ia, Ib, II, III, IV, and V) cause nearly all group B streptococcal (GBS) disease globally. Capsular polysaccharide (CPS) conjugate vaccines aim to prevent GBS disease, however, licensure of a vaccine would depend on a standardi
Externí odkaz:
https://doaj.org/article/f4c53aff34804660864c1dfd08279223
Autor:
Kirsty Le Doare, Michelle A. Gaylord, Annaliesa S. Anderson, Nick Andrews, Carol J. Baker, Shanna Bolcen, Arif Felek, Peter C. Giardina, Christopher D. Grube, Tom Hall, Bassam Hallis, Alane Izu, Shabir A. Madhi, Pete Maniatis, Mary Matheson, Fatme Mawas, Andrew McKeen, Julia Rhodes, Bailey Alston, Palak Patel, Stephanie Schrag, Raphael Simon, Charles Y. Tan, Stephen Taylor, Gaurav Kwatra, Andrew Gorringe
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTMeasurement of IgG antibodies against group B streptococcus (GBS) capsular polysaccharide (CPS) by use of a standardized and internationally accepted multiplex immunoassay is important for the evaluation of candidate maternal GBS vaccines in
Externí odkaz:
https://doaj.org/article/46ead07e882e4125ad972a32edff7d7d
Autor:
Berri, Mario
Publikováno v:
Il Foro Italiano, 1957 Jan 01. 80, 2035/2036-2039/2040.
Externí odkaz:
https://www.jstor.org/stable/23147129
Publikováno v:
Il Foro Italiano, 1910 Jan 01. 35, 1311/1312-1315/1316.
Externí odkaz:
https://www.jstor.org/stable/23113120
Publikováno v:
Il Foro Italiano, 1904 Jan 01. 29, 1081/1082-1083/1084.
Externí odkaz:
https://www.jstor.org/stable/23106696
Publikováno v:
Il Foro Italiano, 1888 Jan 01. 13, 229/230-231/232.
Externí odkaz:
https://www.jstor.org/stable/23098636
Publikováno v:
Il Foro Italiano, 1915 Jan 01. 40, 541/542-545/546.
Externí odkaz:
https://www.jstor.org/stable/23117104
Autor:
Yasunori Ishihara, Mitsuru Fukazawa, Shinya Enomoto, Richard de Solom, Masako Yamaji, Mary Kline, Masakazu Aizawa, Yahong Peng, Osamu Kogawara, Peter C. Giardina, Noor Tamimi, William C. Gruber, Wendy Watson
Publikováno v:
International Journal of Infectious Diseases, Vol 141, Iss , Pp 106942- (2024)
Objectives: Safety and immunogenicity evaluation of a 4-dose series with 20-valent pneumococcal conjugate vaccine (PCV20). Methods: This phase 3, double-blind study randomized healthy Japanese infants to receive 4 doses (3 infant doses, 1 toddler dos
Externí odkaz:
https://doaj.org/article/e0e45f2660a14988b484febfbc2f4db8
Autor:
Michael W. Simon, Regine Bataille, Nicole S. Caldwell, Bradford D. Gessner, Luis Jodar, Erik Lamberth, Yahong Peng, Daniel A. Scott, Lanyu Lei, Peter C. Giardina, William C. Gruber, Kathrin U. Jansen, Allison Thompson, Wendy Watson
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 2 (2023)
ABSTRACTUse of pneumococcal conjugate vaccines (PCVs) has led to substantial reductions in the global burden of pediatric pneumococcal disease. Expansion of serotype coverage has been achieved by increasing PCV valency, but this may carry the potenti
Externí odkaz:
https://doaj.org/article/eee4a903246c45198a86e37958cb0a5c
Autor:
Kai Chu, Yuemei Hu, Hongxing Pan, Jingliang Wu, Dandan Zhu, Mariano M. Young, Li Luo, Zhuobiao Yi, Peter C. Giardina, William C. Gruber, Daniel A. Scott, Wendy Watson
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 2 (2023)
Streptococcus pneumoniae causes a considerable disease burden among children in China. Many isolates exhibit antimicrobial resistance but are often serotypes covered by the 13-valent pneumococcal conjugate vaccine (PCV13). Because the approved infant
Externí odkaz:
https://doaj.org/article/7ff57e54ee8d442ab81f92b884b68d48